You are here

Bayer AG

Bayer is an innovation company with a more than 150-year history and core competencies in the areas of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. In 2015, Bayer posted sales of EUR 46.3 billion with 116,800 employees (operating with its Group companies in 77 countries). 

For Bayer, sustainability fundamentally means future viability and, as part of the corporate strategy, is an integral part of our day-to-day work routines. We are convinced that we can only achieve lasting commercial success if we balance economic growth with ecological and social responsibility. Responsibility for steering and aligning our Group-wide sustainability strategy lies with the Group Board of Management member responsible for Human Resources, Technology and Sustainability in his function as Chief Sustainability Officer, and with a Sustainability Council chaired by the Head of Sustainability & Business Stewardship (W. Grosse Entrup).

News of our Members

10/16/2014 | Bayer included in the Dow Jones Sustainability World Index for the 15th time in succession

Bayer is once again included in the Dow Jones Sustainability World Index (DJSI World). Bayer is thus listed in the DJSI World for the 15th time in succession since the index was established in 1999 – like only 14 other companies worldwide. This confirms Bayer's position as one of the leading companies in the pharmaceutical industry in the area of sustainability.

08/26/2014 | New Successes for Bayer's CO2 Research

Plastics and their components are normally based entirely on oil. The new process also extends the range of plastics that CO2 can be used to produce. This is the result of the Dream Polymers research project in which Bayer MaterialScience is continuing its activities to find new uses for CO2

06/02/2014 | Bayer MaterialScience successful with global efficiency system: Significantly lower energy consumption in chemical production

Bayer MaterialScience, a leading materials manufacturer, will in the future need far less energy for the majority of its global production. This is being made possible by a home-grown energy management system. Its introduction has now been completed. It enables the individual consumption of the production plants to be optimally controlled and reduced by an average of a tenth, and also brings about considerable reductions in CO2 emissions. The system, which is called STRUCTese®, can also be used by other companies under license.

11/14/2012 | Bayer: improving people’s lives through innovation

  • Some EUR 3 billion for research and development in 2012
  • More than 600 patent applications submitted last year
  • Currently 35 clinical development projects in the pharmaceuticals pipeline
  • Five pharmaceutical products with approximate peak annual sales potential of more than EUR 5.5 billion
  • Strong CropScience pipeline with peak sales potential exceeding EUR 4 billion
  • Increasing significance of partnerships – more than 800 R&D collaborations
Econsense

Forum for Sustainable Development of German Business e.V.

econsense is an association of leading, globally active companies and organisations of German business specializing in the area of sustainable development and corporate social responsibility (CSR). Founded in 2000 on the initiative of the Federation of German Industries (BDI), the goal of econsense is to provide a dialogue platform and think tank, with the dual objectives of advancing sustainable development in business and assuming social responsibility.